After the Gravy Days: Opportunities for Biotech Growth
Mar 19, 2012, 00:05 AM
by
Michael Croft
Forbes, Wall Street Journal | In an article on biotech funding on Friday, the Wall Street Journal did not mince words: "The gravy days are over," the authors said, comparing fundraising to the housing market for sellers: tough. Forbes contributor David Shaywitz looks at where the opportunities are for disruptive growth in this environment.
March 19, 2012 | In an article on biotech funding on Friday, the Wall Street Journal did not mince words: "The gravy days are over," the authors said, comparing fundraising to the housing market for sellers: tough. Forbes contributor David Shaywitz looks at where the opportunities are for disruptive growth in this environment and identifies digital health as a possiblility. Forbes, Wall Street Journal